Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

145.13 -3.04 (-2.05%)
Streaming Delayed Price Updated: 11:59 AM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
23 24 Next >
News headline image
These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022 ↗
We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022. 
Via Talk Markets
News headline image
7 Top-Rated Biotech Stocks to Buy for Q4 ↗
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter. 
Via InvestorPlace
News headline image
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry ↗
President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks. 
Via InvestorPlace
News headline image
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary ↗
 
Via Benzinga
News headline image
Mizuho Bolsters Price Target By 55% On This Migraine Stock ↗
 
Via Benzinga
News headline image
Analyst Ratings for Axsome Therapeutics ↗
Within the last quarter, Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings: 
Via Benzinga
News headline image
Expert Ratings for Axsome Therapeutics ↗
Within the last quarter, Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings: 
Via Benzinga
News headline image
Boxed Warnings May Not Hinder This Depression Drug's Broad Market Penetration, Analyst Says ↗
 
Via Benzinga
News headline image
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
Axsome Therapeutics Commences Late-Stage Migraine Study ↗
Axsome Therapeutics (NASDAQ: AXSM) has enrolled the first patient in the EMERGE trial of its lead candidate AXS-07 for the acute treatment of migraine. 
Via Benzinga
News headline image
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know ↗
After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar. 
Via Benzinga
News headline image
HC Wainwright Boosts Price Target On This Stock By 167%, Plus B of A Securities Predicts $40 For This Online Travel Stock ↗
HC Wainwright & Co. raised the price target for Rockwell Medical, Inc. (NASDAQ: RMTI) from $3 to $8. Rockwell Medical shares rose 0.7% to close at $1.42 on Monday. 
Via Benzinga
News headline image
$1000 Invested In Axsome Therapeutics 5 Years Ago Would Be Worth This Much Today ↗
Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 5 years by 57.38% on an annualized basis producing an average annual return of 67.54%. Currently, Axsome Therapeutics has a... 
Via Benzinga
News headline image
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others ↗
These names are benefitting from M&A, clinical data and promising regulatory actions. 
Via Investor's Business Daily
News headline image
AXSOME THERAPEUTICS INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Axsome Therapeutics, Inc. - AXSM
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
AMC Entertainment Price Target Cut By This Analyst, Plus DA Davidson Predicts $318 For Estée Lauder ↗
DA Davidson cut the price target for The Estée Lauder Companies Inc. (NYSE: EL) from $342 to $318. Estée Lauder shares fell 0.4% to $264.29 in pre-market trading. 
Via Benzinga
News headline image
Netflix Price Target Cut By This Analyst, Plus Morgan Stanley Predicts $403 For McKesson ↗
UBS cut the price target for Coupa Software Incorporated (NASDAQ: COUP) from $84 to $76. Coupa Software shares fell 4.9% to $64.44 in pre-market trading. 
Via Benzinga
News headline image
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday ↗
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday. 
Via Benzinga
News headline image
Stocks That Made New Highs On Friday, Aug. 19 ↗
On Friday, in spite of the stock market being down, there were several stocks that actually made new highs. 
Via Talk Markets
News headline image
Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
S&P 500 Down More Than 1%; Bed Bath & Beyond Shares Plummet ↗
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 250 points on Friday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
  
Via Benzinga
News headline image
Axsome Therapeutics Rockets After Winning FDA Approval For A New Depression Drug ↗
Axsome's drug targets a neurotransmitter believed to play a role in depression. 
Via Investor's Business Daily
News headline image
Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session ↗
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday. 
Via Benzinga
News headline image
How Is The Market Feeling About Axsome Therapeutics? ↗
Axsome Therapeutics's (NASDAQ:AXSM) short percent of float has fallen 3.86% since its last report. The company recently reported that it has 5.75 million shares sold short, which... 
Via Benzinga
News headline image
Nasdaq Dips 250 Points; Crude Oil Moves Higher ↗
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 250 points on Friday. 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Axsome Therapeutics Stock In The Last 5 Years ↗
Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 5 years by 52.74% on an annualized basis producing an average annual return of 64.23%. Currently, Axsome Therapeutics has a... 
Via Benzinga
News headline image
General Motors, Foot Locker And Some Other Big Stocks Recording Gains On Friday ↗
  GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday. 
Via Benzinga
News headline image
GCT Stock Alert: What Is Going on With GigaCloud Technology Today? ↗
GigaCloud Technology (GCT) stock is continuing to rally on Friday after the Hong Kong-based fintech company launched its IPO yesterday. 
Via InvestorPlace
News headline image
Why Is Volcon (VLCN) Stock Up 56% Today? ↗
Volcon (VLCN) stock is rocketing higher on Friday after the EV company revealed massive pre-production orders for its Stag. 
Via InvestorPlace
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.